Hospital
East Ohio Hospital LLC
East Ohio Hospital LLC was paid $6.15M by Medicaid between Feb 2021 and Dec 2024, across 162 billing codes. Its largest line is 99283, emergency room visit (moderate) — 17% of everything it billed.
33Billing provider infoEAST OHIO HOSPITAL LLC
MARTINS FERRY, OH 43935
MARTINS FERRY, OH 43935
33aNPI1508480922assigned 06/01/2020
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.15M
24GClaims243,472
24DCodes billed162
24AFirst – last monthFeb 2021 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#87 of 101
Median peer was paid$22.32M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 27,289 | $604K | |
| 2022 | 44,656 | $1.24M | |
| 2023 | 102,467 | $2.29M | |
| 2024incomplete | 69,060 | $2.01M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 12,690 | 10,914 | $1.07M |
| 96361 | Intravenous infusion, hydration; each additional hour | 16% | 4,488 | 3,517 | $994K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 7,836 | 6,409 | $720K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.0% | 3,292 | 2,592 | $368K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 6.0% | 1,861 | 1,524 | $366K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.4% | 1,630 | 1,338 | $268K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.2% | 3,277 | 3,034 | $259K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.0% | 809 | 638 | $186K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.6% | 1,756 | 1,331 | $162K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2.1% | 815 | 651 | $130K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.0% | 2,152 | 535 | $123K |
| 80053 | Comprehensive metabolic panel | 1.9% | 17,625 | 13,566 | $119K |
150 more codes
| G0378 | Hospital observation service, per hour | 1.8% | 1,296 | $112K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.6% | 11,645 | $101K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.6% | 1,254 | $97K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.5% | 1,191 | $91K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.2% | 4,962 | $75K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 253 | $53K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 362 | $49K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,037 | $49K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,972 | $47K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 17,093 | $40K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,602 | $36K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,980 | $36K |
| 80061 | Lipid panel | <1% | 3,379 | $32K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,791 | $32K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,717 | $30K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 897 | $29K |
| 97014 | <1% | 981 | $28K | |
| 82607 | <1% | 1,089 | $19K | |
| 84439 | <1% | 1,293 | $19K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,944 | $18K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,356 | $17K |
| 88142 | <1% | 1,082 | $17K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 454 | $15K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 900 | $15K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,381 | $15K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 385 | $13K |
| 36000 | <1% | 1,834 | $12K | |
| 76830 | Ultrasound, transvaginal | <1% | 328 | $12K |
| 72131 | <1% | 173 | $12K | |
| 73630 | <1% | 605 | $12K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,731 | $12K |
| 71045 | Radiologic examination, chest; single view | <1% | 5,333 | $12K |
| 81001 | <1% | 9,463 | $11K | |
| 73030 | <1% | 502 | $10K | |
| 73130 | <1% | 530 | $10K | |
| 73610 | <1% | 585 | $10K | |
| 85027 | <1% | 1,483 | $10K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 725 | $10K |
| 72110 | <1% | 219 | $6K | |
| 71250 | <1% | 138 | $6K | |
| 83735 | <1% | 2,492 | $6K | |
| 82746 | <1% | 483 | $6K | |
| 84484 | <1% | 4,943 | $6K | |
| 86140 | <1% | 571 | $5K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,469 | $5K |
| 87070 | <1% | 511 | $5K | |
| 74018 | <1% | 335 | $5K | |
| 85610 | <1% | 2,652 | $5K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 5,948 | $5K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 284 | $5K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 322 | $5K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 114 | $4K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 36 | $4K |
| 73562 | <1% | 93 | $4K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 386 | $4K |
| 86850 | <1% | 236 | $4K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 44 | $4K |
| 73110 | <1% | 243 | $4K | |
| 87480 | <1% | 349 | $3K | |
| 97162 | <1% | 305 | $3K | |
| 95886 | <1% | 16 | $3K | |
| 83540 | <1% | 330 | $3K | |
| 87660 | <1% | 349 | $3K | |
| 84153 | <1% | 181 | $3K | |
| 94375 | <1% | 25 | $2K | |
| 82043 | <1% | 451 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,599 | $2K |
| 87205 | <1% | 481 | $2K | |
| 73560 | <1% | 70 | $2K | |
| 82140 | <1% | 422 | $2K | |
| 86900 | <1% | 256 | $2K | |
| 87510 | <1% | 349 | $2K | |
| 83690 | <1% | 2,819 | $2K | |
| 73502 | <1% | 88 | $2K | |
| 80076 | <1% | 151 | $2K | |
| 87634 | <1% | 558 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,822 | $2K |
| 82550 | <1% | 2,426 | $1K | |
| 80320 | <1% | 235 | $1K | |
| J3490 | Unclassified drugs | <1% | 878 | $1K |
| 73564 | <1% | 245 | $1K | |
| 85730 | <1% | 2,104 | $1K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 384 | $1K |
| 83605 | <1% | 1,343 | $1K | |
| 97161 | <1% | 27 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 82 | $1K |
| 85651 | <1% | 484 | $1K | |
| 86901 | <1% | 256 | $1K | |
| 82728 | <1% | 61 | $1K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 910 | $1K |
| 73100 | <1% | 19 | $998.04 | |
| 81025 | <1% | 2,137 | $966.84 | |
| 83880 | <1% | 728 | $953.13 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,538 | $755.72 |
| 90715 | <1% | 74 | $723.24 | |
| 82805 | <1% | 23 | $647.70 | |
| 84703 | <1% | 265 | $565.72 | |
| 96376 | <1% | 573 | $551.16 | |
| 83550 | <1% | 75 | $519.81 | |
| 84702 | <1% | 41 | $461.63 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 16 | $446.52 |
| 87040 | <1% | 961 | $433.23 | |
| 80143 | <1% | 349 | $420.52 | |
| 82077 | <1% | 264 | $418.43 | |
| 84145 | <1% | 367 | $405.49 | |
| 84436 | <1% | 27 | $395.11 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,381 | $361.49 |
| 85379 | <1% | 822 | $344.83 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 978 | $330.74 |
| 73090 | <1% | 18 | $289.27 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,342 | $282.95 |
| 83001 | <1% | 13 | $281.80 | |
| 80179 | <1% | 347 | $266.50 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 632 | $235.19 |
| 82565 | <1% | 22 | $228.83 | |
| 80164 | <1% | 13 | $196.29 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,983 | $169.73 |
| 80074 | <1% | 13 | $168.39 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,323 | $166.84 |
| 84403 | <1% | 13 | $162.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 721 | $160.99 |
| 87081 | <1% | 197 | $158.08 | |
| 94760 | <1% | 3,816 | $156.71 | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 18 | $152.64 |
| 84146 | <1% | 22 | $147.35 | |
| 70486 | <1% | 13 | $123.81 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 93 | $117.81 |
| 86308 | <1% | 32 | $115.08 | |
| 84100 | <1% | 138 | $110.92 | |
| 84520 | <1% | 17 | $92.70 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 529 | $78.31 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 298 | $76.46 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 126 | $67.68 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,157 | $61.25 |
| 87428 | <1% | 20 | $55.70 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,217 | $51.14 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 528 | $43.32 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 136 | $28.40 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 291 | $19.91 |
| 86618 | <1% | 15 | $15.77 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,669 | $13.10 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 45 | $11.85 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 633 | $3.40 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 79 | $2.70 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 78 | $2.45 |
| 94761 | <1% | 700 | $1.93 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 74 | $1.35 |
| A9270 | Non-covered item or service | 0% | 1,010 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 17 | $0.00 |
| 29125 | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialALBERTINI, BERNIE (CHIEF OPERATING OFFICER)
| Provider | Location | Paid |
|---|---|---|
| East Ohio Hospital LLC | Martins Ferry, OH | $1.67M |
| Belmont County Hospital Ambulance LLC | Martins Ferry, OH | $130K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.